Legend Biotech Corp (LEGN) Non-Current Assets (2019 - 2024)
Legend Biotech (LEGN) has disclosed Non-Current Assets for 6 consecutive years, with -$1.3 billion as the latest value for Q4 2024.
- For the quarter ending Q4 2024, Non-Current Assets rose 14.28% year-over-year to -$1.3 billion, compared with a TTM value of -$3.8 billion through Dec 2024, changed N/A, and an annual FY2024 reading of -$1.3 billion, up 14.28% over the prior year.
- Non-Current Assets was -$1.3 billion for Q4 2024 at Legend Biotech, up from -$1.5 billion in the prior quarter.
- Across five years, Non-Current Assets topped out at $164.9 million in Q4 2021 and bottomed at -$1.5 billion in Q4 2023.
- Average Non-Current Assets over 5 years is -$717.6 million, with a median of -$1.1 billion recorded in 2022.
- The sharpest move saw Non-Current Assets soared 58.97% in 2020, then crashed 766.5% in 2022.
- Year by year, Non-Current Assets stood at $128.1 million in 2020, then rose by 28.69% to $164.9 million in 2021, then plummeted by 766.5% to -$1.1 billion in 2022, then plummeted by 36.27% to -$1.5 billion in 2023, then rose by 14.28% to -$1.3 billion in 2024.
- Business Quant data shows Non-Current Assets for LEGN at -$1.3 billion in Q4 2024, -$1.5 billion in Q4 2023, and -$1.1 billion in Q4 2022.